-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.006.76% Upside
CASI Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover CASI Pharmaceuticals, Inc.?
CASI Pharmaceuticals, Inc. has been rated by research analysts at H.C. Wainwright in the past 90 days.